Lobo YA, Bonazza C, Batista FP, Castro RA, et al. EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines. Cancer Lett 2020 Aug 22. pii: S0304-3835(20)30431.
PMID: 32841713